{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:37:44Z","timestamp":1793317064799,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113775","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T03:52:28Z","timestamp":1628740348000},"page":"113775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer"],"prefix":"10.1016","volume":"225","author":[{"given":"Dongdong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0345-6850","authenticated-orcid":false,"given":"Xiaochun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaitian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbiao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113775_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2014.59.7633","article-title":"Metastatic colorectal cancer: current state and future directions","volume":"33","author":"Fakih","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"2017","key":"10.1016\/j.ejmech.2021.113775_bib2","first-page":"177","article-title":"Colorectal cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2021.113775_bib3","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2021.113775_bib4","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase","volume":"6","author":"Salonga","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113775_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2021.113775_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834015614530","article-title":"Pharmacologic resistance in colorectal cancer: a review","volume":"8","author":"Hammond","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejmech.2021.113775_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2021.113775_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ejmech.2021.113775_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113775_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113775_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc2892","article-title":"Evolutionary dynamics of cancer prevention","volume":"10","author":"Gatenby","year":"2010","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2021.113775_bib12","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/ijc.23822","article-title":"Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fluoropyrimidine-based chemotherapy: evidence from 24 studies","volume":"123","author":"Qiu","year":"2008","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113775_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/djh015","article-title":"Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate","volume":"96","author":"Sohn","year":"2004","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2021.113775_bib14","doi-asserted-by":"crossref","first-page":"9775","DOI":"10.3748\/wjg.v20.i29.9775","article-title":"Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years","volume":"20","author":"Panczyk","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2021.113775_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/annonc\/mdm599","article-title":"Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy","volume":"19","author":"Soong","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2021.113775_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.taap.2004.08.018","article-title":"5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice","volume":"203","author":"Innocenti","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113775_bib17","first-page":"4705","article-title":"Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene","volume":"6","author":"van Kuilenburg","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113775_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2217\/pgs.10.167","article-title":"5-Fluorouracil pharmacogenomics: still rocking after all these years?","volume":"12","author":"Scartozzi","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejmech.2021.113775_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00280-015-2746-3","article-title":"Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients","volume":"76","author":"van Staveren","year":"2015","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113775_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3892\/or.2014.3299","article-title":"Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer","volume":"32","author":"Ochiai","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2021.113775_bib21","first-page":"2000","article-title":"Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug","volume":"5","author":"Hirata","year":"1999","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113775_bib22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0959-8049(02)00048-5","article-title":"Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells","volume":"38","author":"Takechi","year":"2002","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113775_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104717","article-title":"S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer","volume":"155","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113775_bib24","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1039\/C5OB00951K","article-title":"A\u00a0potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression","volume":"13","author":"Yue","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113775_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bmcl.2016.01.031","article-title":"Discovery of novel S1P2 antagonists, part 3: improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives","volume":"26","author":"Kusumi","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113775_bib26","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1016\/j.bmcl.2015.09.022","article-title":"Discovery of novel S1P2 antagonists. Part 2: improving the profile of a series of 1,3-bis(aryloxy)benzene derivatives","volume":"25","author":"Kusumi","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113775_bib27","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bmcl.2015.02.029","article-title":"Discovery of novel S1P2 antagonists. Part 1: discovery of 1,3-bis(aryloxy)benzene derivatives","volume":"25","author":"Kusumi","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113775_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bmcl.2017.12.010","article-title":"Design and synthesis of pyrazolopyridine derivatives as sphingosine 1-phosphate receptor 2 ligands","volume":"28","author":"Luo","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113775_bib29","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.bmc.2019.06.047","article-title":"Design, synthesis, and in\u00a0vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor","volume":"27","author":"Luo","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113775_bib30","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.bmc.2013.06.012","article-title":"A\u00a0sphingosine 1-phosphate receptor 2 selective allosteric agonist","volume":"21","author":"Satsu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113775_bib31","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1016\/j.tetlet.2014.08.087","article-title":"Direct access to 2-aminopyrazolo[1,5-a]pyridines via N-amination\/cyclization reactions of 2-pyridineacetonitriles","volume":"55","author":"Nishigaya","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113775_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphar.2020.00141","article-title":"Local irradiation modulates the pharmacokinetics of metabolites in 5-fluorouracil-radiotherapy-pharmacokinetics phenomenon","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113775_bib33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.prp.2014.06.016","article-title":"Association of CD98, integrin beta1, integrin beta3 and Fak with the progression and liver metastases of colorectal cancer","volume":"210","author":"Sun","year":"2014","journal-title":"Pathol. Res. Pract."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:30:48Z","timestamp":1759329048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421006243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"alternative-id":["S0223523421006243"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113775","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113775"}}